MedTrace Logo

Role of Ondansetron in Spinal Anaesthesia Induced Hypotension

NCT06727201 · Status: NOT_YET_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2024-12-10

No results posted yet for this study

Summary

The objective of this study is to determine the effect of ondansetron on the total consumption of norepinephrine infusion needed to prevent spinal anaesthesia induced hypotension in cesarean section.

Conditions

  • Spinal Anaesthesia Induced Hypotension

Interventions

DRUG

Ondansetron (Zofran)

Ondansetron will be given intravenously in a dose of 0.1mg/kg 10 minutes before spinal anaesthesia as single shot.

DRUG

Saline (NaCl 0,9 %) (placebo)

normal saline infusion will be given intravenously 10 minutes before spinal anaesthesia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mohamed H Bakri, professor · Assiut University

  • Ola M Wahba, A.professor · Assiut University

  • Abdelrahman H Mohammed, A.professor · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-12-01
Completion
2027-02-01
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06727201 on ClinicalTrials.gov